.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

ACCC Annual Conference

Posters From AMCCBS and AAD Showcase New Technology for Biosimilar Uptake, Barriers to Self-Injectable Biologics

March 14th 2024

Article

Posters from Association of Cancer Care Centers 50th Annual Meeting and Cancer Center Business Summit (AMCCBS) and the American Academy of Dermatology (AAD) highlight the benefits of incorporating biosimilars into electronic medical records and the biggest barriers for home injection of biologics.

Joseph Alvarnas, MD, Discusses Biosimilar Use at City of Hope

March 10th 2021

Video

Joseph Alvarnas, MD, a recent presenter at the Association of Community Cancer Centers annual meeting, discussed efforts to implement biosimilars at City of Hope, a clinical research center, hospital, and graduate medical school in Duarte, California.

Oncologists' Cost Sensitivity May Drive Biosimilar Uptake

March 9th 2021

Article

Sonia T. Oskouei, PharmD, BCMAS, DPLA, vice president of Biosimilars at Cardinal Health, discusses motivating factors that affect use of biosimilars in oncology.

Cardinal Health: Oncologists’ Comfort With Biosimilars Is on the Increase

March 8th 2021

Article

Survey results show that oncologists are embracing biosimilars not just in supportive care but for therapeutic uses also.

ACCC Virtual: Dr Wilfong of Texas Oncology Discusses Biosimilar Integration

March 5th 2021

Video

Lalan Wilfong, MD, an expert on value-based care, explains how Texas Oncology worked with physicians and payers to make biosimilars available for patients.